Tred Avon Family Wealth LLC Takes Position in Sabra Healthcare REIT, Inc. $SBRA

Tred Avon Family Wealth LLC bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 52,507 shares of the real estate investment trust’s stock, valued at approximately $979,000.

A number of other hedge funds also recently bought and sold shares of the business. EverSource Wealth Advisors LLC grew its position in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after buying an additional 1,536 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Sabra Healthcare REIT by 685.7% during the third quarter. Farther Finance Advisors LLC now owns 3,952 shares of the real estate investment trust’s stock valued at $74,000 after acquiring an additional 3,449 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in Sabra Healthcare REIT in the second quarter worth $84,000. Hilltop National Bank bought a new stake in Sabra Healthcare REIT in the second quarter valued at $96,000. Finally, Allworth Financial LP increased its position in Sabra Healthcare REIT by 105.9% during the 2nd quarter. Allworth Financial LP now owns 5,213 shares of the real estate investment trust’s stock valued at $96,000 after purchasing an additional 2,681 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on SBRA shares. UBS Group started coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price for the company. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Friday, October 17th. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Saturday, January 3rd. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $21.00.

Check Out Our Latest Analysis on SBRA

Sabra Healthcare REIT Price Performance

SBRA stock opened at $19.24 on Friday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. The firm has a 50 day moving average price of $19.03 and a 200-day moving average price of $18.68. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $19.97. The firm has a market capitalization of $4.80 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 1.17 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.01. The company had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.2%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s payout ratio is currently 166.67%.

About Sabra Healthcare REIT

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Featured Articles

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.